Comprehensive update on the new indications for transcatheter aortic valve replacement in the latest 2017 European guidelines for the management of valvular heart disease.

Authors :: Thonghong T
De Backer O
Søndergaard L
Source :: Open heart [Open Heart] 2018 Feb 23; Vol. 5 (1), pp. e000753. Date of Electronic Publication: 2018 Feb 23 (Print Publication: 2018).
Publication Year :: 2018
Abstract: New European guidelines on the management of valvular heart disease-supported by the European Society of Cardiology (ESC) and European Association of CardioThoracic Surgery (EACTS)-were recently published. Although these guidelines are very comprehensive, these typically are not very inviting to read. In this document, we aimed to distil all the information about transcatheter aortic valve replacement (TAVR) in the new 2017 ESC/EACTS guidelines to the essential and give additional comments on the position of TAVR in 2017.<br />Competing Interests: Competing interests: None declared.

Full Text Access

Tools